Astrazeneca Pharma India informs about updates

20 Jan 2024 Evaluate
Astrazeneca Pharma India has informed that AstraZeneca Pharma India has received permission to Import pharmaceutical formulations of new drug for sale or for distribution in Form CT-20 from Central Drugs Standard Control Organisation for Andexanet alfa powder for solution for infusion 200mg (Andexxa).

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

5482.00 66.60 (1.23%)
29-Apr-2024 10:56 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1519.00
Dr. Reddys Lab 6265.55
Cipla 1398.45
Zydus Lifesciences 964.60
Lupin 1634.65
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.